Integrated analysis and validation reveal CYTH4 as a potential prognostic biomarker in acute myeloid leukemia.

"Competing interests The authors declare that they have no competing interests."

"The present study was supported by grants from the National Natural Science Foundation of China (grant nos. 82070161 and 81870134), the China Postdoctoral Science Foundation (grant no. 2022TQ0217), the Natural Science Foundation of Guangdong Province (grant no. 2022A1515012465), the Natural Foundation of Shenzhen Science and Technology Innovation Commission (grant no. JCYJ20220531103003007), the Natural Science Foundation of Shenzhen University General Hospital (grant no. SUGH2020QD008), the Shenzhen Key Laboratory Foundation (grant no. ZDSYS20200811143757022), the Sanming Project of Shenzhen (grant no. SZSM202111004) and the Medical-Engineering Interdisciplinary Research Foundation of ShenZhen University (grant no. 00000305)."